Ken Griffin Vapotherm Inc Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.48 - $16.88 $3,961 - $139,310	8,253 New	8,253 $22,000
Q2 2022 Aug 15, 2022	BUY	$2.52 - $14.42 $58,154 - $332,770	23,077 Added 91.75%	48,228 $122,000
Q1 2022 May 16, 2022	SELL	$12.69 - $20.72 $1.38 Million - $2.26 Million	-109,059 Reduced 81.26%	25,151 $350,000
Q4 2021 Feb 14, 2022	BUY	$19.7 - $23.71 $460,113 - $553,770	23,356 Added 21.07%	134,210 $0
Q3 2021 Nov 15, 2021	SELL	$21.32 - $29.36 $2.02 Million - $2.78 Million	-94,637 Reduced 46.05%	110,854 $2.47 Million
Q2 2021 Aug 16, 2021	BUY	$17.01 - $24.14 $1.93 Million - $2.74 Million	113,482 Added 123.34%	205,491 $0
Q1 2021 May 17, 2021	SELL	$21.8 - $36.52 $421,917 - $706,808	-19,354 Reduced 17.38%	92,009 $2.21 Million
Q4 2020 Feb 16, 2021	BUY	$23.44 - $31.85 $1.74 Million - $2.37 Million	74,345 Added 200.83%	111,363 $2.99 Million
Q3 2020 Nov 16, 2020	SELL	$25.1 - $53.8 $2.98 Million - $6.39 Million	-118,733 Reduced 76.23%	37,018 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$16.0 - $40.99 $2.24 Million - $5.73 Million	139,811 Added 877.11%	155,751 $6.38 Million
Q1 2020 May 15, 2020	BUY	$7.79 - $19.91 $124,172 - $317,365	15,940 New	15,940 $300,000

1.29M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.